Subscribe to STAT+ and access exclusive benefits this month JOIN STAT+
The Food and Drug Administration’s traditional approval process involves a series of rigorous clinical trials that can take as long as a decade to set up, oversee, and evaluate. Now, however, some of the ways the FDA speeds up the drug approval process are coming under increasing scrutiny. Our latest report unpacks the differences between the ways the FDA approves drugs, like accelerated approvals, fast-track designations, and emergency use authorizations — and how those pathways could change in the future.
STAT+ Subscribers get a 20% discount on all report purchases. Learn more Date: June 3, 2022
Time: 5:30 p.m. EST
Location: Chicago, IL
As doctors and researchers return to ASCO, STAT reporters will sit down with newsmakers driving science and cancer policy and dig in to what we expect to learn over a packed four days at the biggest gathering for cancer research and the biotech industry. REGISTER Free Pop-up Newsletters
| ADA in 30 Seconds
June 4–6 | STAT reporters will deliver coverage of the American Diabetes Association conference right to your inbox.
Sign up. |
STAT+ Reads In case you missed them, here are some of our favorite STAT+ stories from this past month: Read more | 
No comments